These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9834048)

  • 21. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m.
    Beaumont M; Batéjat D; Coste O; Van Beers P; Colas A; Clère JM; Piérard C
    Neuropsychobiology; 2004; 49(3):154-62. PubMed ID: 15034230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Griebel G; Perrault G; Sanger DJ
    J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are z-hypnotics better and safer sleeping pills than benzodiazepines?].
    Mellingsaeter TC; Bramness JG; Slørdal L
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2954-6. PubMed ID: 17117195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem.
    Farkas D; Volak LP; Harmatz JS; von Moltke LL; Court MH; Greenblatt DJ
    Clin Pharmacol Ther; 2009 Jun; 85(6):644-50. PubMed ID: 19242403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of new hypnotic drugs in rats trained to discriminate ethanol.
    Sanger DJ
    Behav Pharmacol; 1997 Aug; 8(4):287-92. PubMed ID: 9832988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zaleplon pharmacokinetics and absolute bioavailability.
    Rosen AS; Fournié P; Darwish M; Danjou P; Troy SM
    Biopharm Drug Dispos; 1999 Apr; 20(3):171-5. PubMed ID: 10211871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J; Scharf M; Mangano R; Fujimori M
    Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
    Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychomotor effects of zaleplon and thioridazine coadministration.
    Hetta J; Broman JE; Darwish M; Troy SM
    Eur J Clin Pharmacol; 2000 Jun; 56(3):211-7. PubMed ID: 10952475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteers.
    Avram MJ; Spyker DA; Kehne JH; Cassella JV
    J Clin Pharmacol; 2013 Feb; 53(2):140-50. PubMed ID: 23436259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
    Paul MA; Gray G; Kenny G; Pigeau RA
    Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.
    Greenblatt DJ; Legangneux E; Harmatz JS; Weinling E; Freeman J; Rice K; Zammit GK
    J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude.
    Beaumont M; Batéjat D; Piérard C; Van Beers P; Philippe M; Léger D; Savourey G; Jouanin JC
    Sleep; 2007 Nov; 30(11):1527-33. PubMed ID: 18041485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem.
    Follesa P; Mancuso L; Biggio F; Cagetti E; Franco M; Trapani G; Biggio G
    Neuropharmacology; 2002 Feb; 42(2):191-8. PubMed ID: 11804615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Noguchi H; Kitazumi K; Mori M; Shiba T
    J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential impairment of triazolam and zolpidem clearance by ritonavir.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):129-36. PubMed ID: 10935688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.